MedPath

a clinical trial to compare efficacy of the analgesic activity of inj. Bupivacaine vs inj. Ropivacaine given at transverse abdominis block and also compare the safety parameters also.

Phase 4
Registration Number
CTRI/2017/08/009249
Lead Sponsor
Department of Anaesthesiology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ï??Informed written consent for

participation in study.

ï??Age: 20-35 years

ï??Gender: Antenatal female patients

scheduled for elective or non urgent

lower segment cesarean section.

ï??ASA physical status I and II.

ï??Patients refusing consent.

Exclusion Criteria

1.Contraindications to Spinal Anaesthesia like,

Local infection or sepsis at the site of

Lumbar puncture

Bleeding disorders, thrombocytopenia

Space occupying lesions of the brain

Anatomical disorders of the spine

Hypovolaemia e.g. following massive

haemorrhage

2.Allergy to local anaesthetic drugs and NSAIDS.

3.Patient on any form of analgesics therapy.

4.BMI >= 25 kg/m2

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare efficacy and safety of bupivacaine and ropivacaine for post operative pain relief in lower segment cesarean section with Visual Analogue Score and total dose of rescue analgesia.Timepoint: 1st day of lower cesarean section(First 24 hours after lower segment cesarean section)
Secondary Outcome Measures
NameTimeMethod
Effect on hemodynamic variables like Heart Rate (HR), Mean Arterial Pressure (MAP), Oxygen saturation (SpO2). <br/ ><br>Side effects & Complications if any. <br/ ><br>Timepoint: 1st day of lower segment cesarean section (24 hours of lower segment cesarean section)
© Copyright 2025. All Rights Reserved by MedPath